Pneumococcal Vaccine Extended to High-Risk Children, Teens
FDA approves expanded indication for individuals aged 2-17 years with chronic medical conditions. Medscape Medical News Source link : https://www.medscape.com/viewarticle/vaccine-protection-extended-high-risk-children-and-teens-2026a1000kug?src=rss ...













